Response of Primary Renal Cell Carcinoma to Systemic Therapy
Author:
Publisher
Elsevier BV
Subject
Urology
Reference32 articles.
1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018
2. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Escudier;Ann Oncol,2019
3. Role of surgery in advanced/metastatic renal cell carcinoma;Bhat;Indian J Urol,2010
4. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial;Mickisch;Lancet,2001
5. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer;Flanigan;N Engl J Med,2001
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC);Frontiers in Oncology;2023-03-29
2. A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs);Frontiers in Pharmacology;2023-01-04
3. Soluble CD163: a novel independent prognostic biomarker in patients with metastatic renal cell carcinoma;Cancer Immunology, Immunotherapy;2022-08-11
4. GPNMB overexpression is associated with extensive bone metastasis and poor prognosis in renal cell carcinoma;Oncology Letters;2021-12-01
5. Dynamic biomarker and imaging changes from a phase II study of pre‐ and post‐surgical sunitinib;BJU International;2021-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3